FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer
In summary, the findings of the study indicate that elevated FSTL1 expression could serve as a prognostic biomarker for unfavorable outcomes in colorectal cancer (CRC) diagnosis and may also identify potential targets for immunotherapy in CRC.
Authors
- Zhaorui Cheng
- Xiaojuan Yang (ORCID: https://orcid.org/0000-0003-1323-9478)
- Xiaowei Chen (ORCID: https://orcid.org/0000-0003-1049-3016)
- Yongqian Shu (ORCID: https://orcid.org/0000-0002-3034-685X)
- Xiushen Li (ORCID: https://orcid.org/0000-0002-7135-7299)
- Jia Hu (ORCID: https://orcid.org/0000-0003-2387-1557)
- Yun Liu (ORCID: https://orcid.org/0009-0009-3681-4843)
- Chao Zhong (ORCID: https://orcid.org/0000-0002-6323-1346)
- Ling He (ORCID: https://orcid.org/0000-0003-3564-8862)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Sun Yat-sen University (CN)
- Jiangxi Maternal and Child Health Hospital (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
- Eighth Affiliated Hospital of Sun Yat-sen University
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1007/s12672-025-03989-9
- Primary Topic
- Kruppel-like factors research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Education Department of Jiangxi Province